FDA NDC Directory · JSON-LD · Markdown

Myalept

NDC 10122-210 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic namemetreleptin
Labeler / ManufacturerChiesi USA, Inc.
Marketing categoryBiologic License Application · App BLA125390
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · SUBCUTANEOUS
Active ingredientsMETRELEPTIN (11.3 mg/2.2mL)
Marketing started20150305
Package count1

External sources

Source: openFDA. Public-domain (CC0).